|
|
||||||||
Free Radical Research Group, Department of Pathology, Christchurch School of Medicine, Christchurch, New Zealand
| |
ABSTRACT |
|---|
|
|
|---|
We investigated the effect of sublethal
concentrations of hypochlorous acid (HOCl) on intracellular thiol
groups. Exposure of human umbilical vein endothelial cells to HOCl
caused a decrease in cell viability, with concentrations of
25 µM
HOCl being sublethal. At these concentrations, we saw a loss of
glutathione and total protein thiol groups. Of the thiol enzymes we
investigated, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
particularly susceptible to inactivation, creatine kinase was
moderately susceptible, and lactate dehydrogenase was unaffected by
HOCl at the concentrations used. Similar results were obtained with
HOCl generated over 30 min by myeloperoxidase. GAPDH activity could be
regenerated on reincubation of cells in Hanks' balanced salt solution
or reduction with dithiothreitol. In contrast, glutathione loss was not
reversible, and further decreased with time. Cellular ATP levels
decreased with sublethal HOCl concentrations and this appeared to be
unrelated to the inactivation of GAPDH. Our results demonstrate that
intracellular thiol groups differ in their reactivity with HOCl and
suggest that HOCl may be able to regulate specific cellular functions.
glyceraldehyde-3-phosphate dehydrogenase; creatine kinase
| |
INTRODUCTION |
|---|
|
|
|---|
HYPOCHLOROUS ACID (HOCl) is a powerful oxidant generated by the neutrophil enzyme myeloperoxidase (MPO) from H2O2 and chloride, and HOCl is thought to play a central role in the antimicrobial action of neutrophils (22). On stimulation and phagocytosis, HOCl production by the neutrophil accounts for up to 70% of the oxygen consumed, making it the major oxidative product of neutrophils (29). Although most of the HOCl generated in the inflammatory locus is directed at the target microorganism, the surrounding tissues are also vulnerable. HOCl has been implicated in the injury associated with neutrophil accumulation in myocardial reperfusion injury (59), inflammatory bowel disease (37), glomerulonephritis (30), rheumatoid arthritis (40), and respiratory distress syndrome (21).
HOCl is highly reactive with a range of biological substrates. It reacts readily with thiols and thioethers, Fe-S centers, and nucleotides (14, 61), with amines to form reactive chloramines (50), and with unsaturated fatty acids to form chlorohydrins (62). A body of work has been published focusing on the lethal, toxic nature of the oxidant, using bacteria (1, 24), red blood cells (56), tumor cells (9, 42), and mammalian cells (18) as targets. Most of this work has concentrated on the membrane as the target for HOCl reacting with cells (1, 4). However, previous work in this laboratory has shown that HOCl is able to pass through cell membranes (7, 58), and in red blood cells intracellular reduced GSH was a primary target (58). These studies have raised the possibility that lower, sublethal levels of HOCl may react with intracellular components and thereby affect cellular functions.
We investigated the reactivity of HOCl with intracellular constituents of cultured human umbilical vein endothelial cells (HUVECs). We investigated the effect of exposure to low levels of HOCl on cellular thiol status because HOCl reacts rapidly with thiol groups (14, 61), and thiol proteins play a crucial role in a number of cell processes, including ion transport, energy metabolism, and transcriptional regulation. The effects of HOCl on GSH, total cellular protein thiols and on the activities of the thiol-containing enzymes GAPDH, lactate dehydrogenase (LDH), and creatine kinase (CK) were investigated. We investigated the ability of the cell to recover from some of the HOCl-mediated redox changes and whether low, sublethal concentrations of HOCl caused depletion of cellular ATP.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Cell culture materials including medium 199, fetal bovine serum and penicillin/streptomycin were from GIBCO-Life Technologies (Auckland, New Zealand). CLS type I collagenase was from Worthington Biochemical (Freehold, NJ) and heparin was from Fisons (Sydney, Australia). Fibronectin was purified from human plasma by affinity chromatography on gelatin Sepharose as previously described (57). Purified human MPO was a gift from Dr. Tony Kettle (27). [51Cr]chromate was supplied by Amersham Australia. Sodium hypochlorite was from Reckitt and Coleman (Auckland, New Zealand). Monobromobimane was from Calbiochem (La Jolla, CA), and pyruvate kinase and lactate dehydrogenase were from Boehringer Mannheim (Mannheim, Germany). The ATP assay kit was supplied by Molecular Probes (Eugene, OR). The apoptosis test kit (Apoptest FITC kit) used to test cell viability was supplied by NeXins Research BV (The Netherlands). Protein was assayed using a kit supplied by Bio-Rad (Hercules, CA). Sigma Chemical (St. Louis, MO) supplied all other chemicals.
Cell culture. After we obtained informed consent from patients, HUVECs were isolated from umbilical cords by collagenase digestion (26). The cells were cultured in medium 199 supplemented with 20% FBS, 100 µg/ml heparin, 30 µg/ml endothelial cell growth factor, 25 U/ml penicillin, and 25 µg/ml streptomycin. Flasks and plates were precoated with 20 µg/ml fibronectin, and cultures were maintained in a 37°C incubator with 5% CO2. Cells were used after the second or third passage. HUVECs were identified by their typical morphology, including the presence of Wiebel-Palade bodies and cobblestone pattern on confluency.
Cell treatment.
HOCl concentration was established by reaction with
5-thio-2-nitrobenzoic acid and measurement of
A412 (
= 28,200 M
1 · cm
1)
(55) or alternatively using the extinction coefficient of hypochlorite
292 = 350 M
1 · cm
1
at pH 10-12 (16). At pH 7.4 solutions contained about equimolar concentrations of HOCl and
OCl
(pKa = 7.6) but are
referred to as HOCl. HOCl was diluted in Hanks' balanced salt solution
(HBSS): PBS, pH 7.4, containing 5.5 mM glucose, 0.5 mM magnesium, and
1.0 mM calcium to final concentrations ranging from 0 to 50 µM.
Confluent cells were washed in HBSS three times, 1 ml of the relevant
HOCl solution was quickly added to each well, and the cells were
incubated at 37°C for the times indicated. In some cases, cells
were reincubated after the 10-min HOCl treatment by removal of the
supernatant and incubation of the cells in fresh HBSS for an additional
hour. All assays were performed in 24-well plates with confluent
cultures (~1.2 × 105
cells/well). Therefore, a 50 µM dose of HOCl is equivalent to ~50
nmol of HOCl per 1.2 × 105
cells. Each well contained ~40 µg of protein.
system, with continuous generation of
H2O2
by glucose oxidase. The
H2O2
generation rate was measured using a YSI model 25 oxidase meter fitted
with a YSI 2510 probe (Yellow Springs Instruments, Yellow Springs, OH),
as described previously (28). HUVECs were exposed to a flux of HOCl by
incubating cells in 1 ml of HBSS containing 100 nM MPO and sufficient
glucose oxidase to give 0, 15, 25, 50, and 100 µM
H2O2
over 30 min at 37°C.
Cytotoxicity assays. Confluent cells were preincubated with [51Cr]chromate in complete medium for 3-4 h, washed in HBSS and exposed to HOCl. Aliquots of the supernatant were removed and spun, and the radioactivity was counted. Released 51Cr is expressed as a percentage of the total cellular radioactivity estimated after lysis with Nonidet P-40 (NP-40).
Alternatively, the number of viable cells was determined using a flow cytometry assay to distinguish between viable, apoptotic, and necrotic cells (52). This assay uses annexin V to detect the phosphatidylserine that transfers to the outer leaflet of the membrane during apoptosis and propidium iodide uptake to detect necrotic cells. Confluent cells were washed and the medium was retained. Cells were then treated with HOCl (0-50 µM) for 1 h at 37°C. The HBSS was removed, centrifuged to pellet any detached cells, and both the detached cells and those remaining on the plate were reincubated in the conditioned medium at 37°C for 5 h. After this procedure, adherent cells were removed from the plate with trypsin, pooled with the previous detached cells, and washed. Annexin V was added according to manufacturer's instructions, along with 1 µl of 2 mg/ml propidium iodide, and the cells were left for 10 min in the dark. The cell fluorescence was measured using a bivariate flow cytometer. Results were analyzed as the percentage of viable cells and expressed as percentage of control (see Fig. 3A).Glutathione measurements. Reduced glutathione was analyzed using an adaptation of the method of Martin and White (36). Cells were treated with HOCl or the MPO system, and thiol groups were blocked with iodoacetic acid and subsequently derivatized with dansyl chloride. Cell extracts were then separated by HPLC, using a 5-µm NH2 silica LiChrospher column (E Merck, Alltech) with a fluorescent detection system (excitation 328 nm and emission 542 nm). The retention times of the cell extract peaks were compared with standard GSH.
Total protein thiols.
After treatment with HOCl, cells were brought to pH 8.0 with KOH, and
reacted with 12 mM monobromobimane for 20 min in the dark (8). Protein
was precipitated with 5% ice-cold perchloric acid and washed three
times with 5% trichloroacetic acid. Samples were resuspended in 1%
sodium dodecyl sulfate and their fluorescence was measured (excitation
394 nm and emission 480 nm). Protein concentrations of samples were
measured using a detergent-compatible Bio-Rad protein assay based on
the Folin-Lowry method. Results are expressed as percent control after
correcting for protein levels. To obtain molar values for control HUVEC
protein thiols, perchloric acid extracts of cells were reacted with 100 µM 5,5'-dithiobis(2-nitrobenzoic acid), and absorbances were
measured at 412 nm (
= 14,100 M
1 · cm
1)
(5).
Enzyme assays. Ten minutes after exposure to HOCl or after 30 min with the MPO system, cells were washed and lysed by the addition of 0.025% NP-40 for 30 min at 37°C. Samples were removed from the well and spun to remove debris, giving a cytoplasmic extract. GAPDH (5), LDH (11), and CK (49) were assayed using standard spectrophotometric techniques adapted for use in a 96-well plate reader.
The ability of the cells to regenerate GAPDH activity was investigated. The enzyme activity was assayed either after reincubation with fresh HBSS for 1 h or in cytoplasmic extracts of the cells that were prepared after 10 min of HOCl treatment then incubated with 5 mM dithiothreitol (DTT) for 1 h at 37°C.ATP levels.
ATP concentrations in cell samples were measured with a Molecular
Probes kit using luciferase and luciferin (12) and a
Bio · Orbit 1253 luminometer. The kit was altered to
make it more sensitive by decreasing the luciferin concentration to 20 µM and increasing the final tricine buffer concentration to 100 µM.
After HOCl treatment, ATP was extracted from cells by adding ice-cold perchloric acid (3% vol/vol), 2 mM EDTA, and 0.5% Triton X-100 to
wells and leaving the wells on ice for 5 min. Extracts
were removed from the well, centrifuged (13,000 g, 1 min), and either snap frozen and
stored at
80°C for later analysis or placed on ice for
analysis that same day. Perchloric acid-extracted samples were
neutralized with a potassium hydroxide solution (2 M KOH, 2 mM EDTA, 50 mM MOPS) and left on ice for 10 min. Samples were then spun and the
supernatant assayed for ATP as per kit instructions.
| |
RESULTS |
|---|
|
|
|---|
Characterization of HOCl cytotoxicity. HOCl is rapidly consumed on addition to HUVECs. With 35 µM HOCl, half of the HOCl was consumed within 30 s of its addition, with the remainder disappearing during the next 15 min. In the subsequent experiments, most of the assays were performed 10 min after the addition of HOCl to the cells.
HOCl (0-50 µM) was added to the cells in a 1-ml volume; addition in a larger volume changes the ratio of oxidant to cells and alters the toxicity profile. Exposure of HUVECs to HOCl (0-50 µM) produced a concentration- and time-dependent release of 51Cr from the cells (Fig. 1). At the higher HOCl concentrations 51Cr leakage was apparent within 30 min of exposure. At these HOCl concentrations, maximum 51Cr release rarely exceeded 50%. However, up to 90% release was seen with higher HOCl concentrations (not shown). At <25 µM HOCl, minimal leakage of 51Cr was observed over time. This correlated well with the visual changes seen in the cells. Control cells looked very similar to cells exposed to 20 µM HOCl after 3 h of treatment (Fig. 2, A and B). Interestingly, 20 µM HOCl at 10 min caused contraction in cells with the formation of intercellular spikes. However, the original morphology was recovered within 1 h of treatment. At higher doses, effects were more extreme; within 10 min of exposure, 50 µM HOCl caused contraction and rounding of the cells (Fig. 2C). Cells were beginning to detach after 1 h, with a majority of cells detached after 3 h (Fig. 2D).
|
|
25 µM HOCl were
sublethal with a progressive decrease in viability above this (Fig.
3B).
|
Cell thiol changes.
With increasing concentrations of HOCl, there was a progressive loss of
intracellular GSH at 10 min posttreatment (Fig.
4). This loss became apparent at
concentrations higher than 10 µM HOCl, and at 50 µM HOCl most of
the GSH was oxidized. At this point the ratio of HOCl added to GSH lost
was ~40. With extended incubation there was an additional drop in GSH
levels. Investigation of the reaction of GSH with HOCl in endothelial
cells indicated that very little GSSG was formed, and that more unusual
products were generated. These results are reported in detail elsewhere (unpublished observations).
|
|
Thiol enzyme inactivation.
GAPDH, LDH, and CK exhibited very different susceptibilities to HOCl
(Fig. 6). GAPDH was particularly sensitive,
with
10 µM HOCl causing a significant loss in activity. CK was
moderately susceptible, whereas LDH underwent only a very small loss in
activity at 50 µM HOCl.
|
system (Fig. 7). GAPDH was particularly
susceptible to inactivation by a continuous generation of HOCl and
creatine kinase was moderately susceptible. A loss in cellular GSH
levels was apparent with a flux of HOCl. These changes were not a
result of the
H2O2
generated by glucose oxidase, as there was no effect in the absence of
MPO (not shown). Thus the relative susceptibilities of these thiols were identical whether HOCl was generated continuously or added in a
bolus.
|
|
ATP levels.
The effect of HOCl exposure on ATP levels was measured to determine
whether the loss in GAPDH activity affected cellular energy status.
After the 10-min treatment, a progressive loss in ATP was observed with
increasing HOCl concentrations above 15 µM (Fig. 9). After reincubation in fresh HBSS for 1 h there was an additional drop in cellular ATP levels, particularly at
the higher HOCl doses. The decreased ATP levels seen at 1 h were
maintained over the next 5 h (not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
Exposure to reactive oxygen species is known to affect cells in a variety of ways. High levels of exposure are cytotoxic, and cell death can occur via an overwhelming onslaught to many vital cell components, including membranes, protein, and DNA (20). More recently it has been demonstrated that low levels of oxidants can modulate cell processes and affect signal transduction (46). In this way sublethal levels of H2O2 have been shown to affect the levels of transcription factors (3) and heat shock proteins (25), the activity of specific kinases (39, 60), and to induce apoptosis (15), cell proliferation (6), and growth arrest (10). Similar effects also occur with nitric oxide (13), organic peroxides (19), and peroxynitrite (31). We were interested in whether HOCl could act in a similar manner. Given the prevalence of neutrophils at inflammatory sites, HOCl and chloramines derived from it are relevant oxidants in vivo. Although neutrophils generally direct their oxidants at phagocytosed organisms, the surrounding tissues can also be a target and can be exposed to varying doses of HOCl or chloramines. In support of this, recent studies have demonstrated the presence of markers of HOCl at inflammation sites (23, 34).
A number of studies have determined the effects of HOCl on cell thiol status and have shown that HOCl can cause GSH loss in erythrocytes (58), neutrophils (7), and other mammalian cells (48). Although previous investigations (7, 48) have shown a loss in GSH and protein thiols, this is the first more detailed look at the relative susceptibilities of GSH and specific thiol proteins at sublethal levels of HOCl exposure. We have shown that low amounts of HOCl, either added as a reagent or generated by MPO cause significant loss of cellular thiols in cultured HUVECs. Both GSH and protein thiols were affected and some thiol-containing enzymes were preferential targets for HOCl. When HOCl was continuously generated by the MPO system over 30 min, the pattern of thiol loss was similar to that seen with a bolus addition of HOCl, indicating that the relative susceptibilities of the targets for HOCl was independent of the time of exposure to the oxidant.
To assess relative susceptibilities of different cell parameters,
including viability, 50% inhibitory concentrations for HOCl were
calculated (Fig. 10). Of the thiols
measured, GAPDH was most susceptible to inactivation by HOCl. The
IC50 value for GAPDH was much
lower than that for the total protein thiols, reinforcing the
comparative sensitivity of GAPDH to HOCl. GSH was more sensitive to
oxidation than the total protein thiol groups, as indicated by its
lower IC50. We have shown a range
of susceptibilities for different thiol proteins and would expect GAPDH
and other sensitive targets to account for the loss in total protein
thiols at the low HOCl concentrations that did not affect GSH.
Particularly at the lower concentrations, a major proportion of the
HOCl could be accounted for, on a molar basis, as thiol loss. Protein
thiols are present at a 15-fold excess over GSH, and accounted for most of this HOCl. Other targets of HOCl are also likely, and could be
significant in HUVECs at higher, lethal doses of HOCl. We have previously detected chloramine formation and protein cross-linking in
red blood cells, and this latter reaction, rather than thiol oxidation,
correlated with red blood cell lysis (54).
|
Our findings that HOCl shows a high reactivity with apparent
selectivity for particular thiols raises the possibility that HOCl
could regulate cell function through specific thiol oxidation. Support
for this idea comes from the finding that HOCl can raise the levels of
the transcription factor p53 in human skin fibroblasts (53). A study by
Schoonbroodt et al. (41) has shown that HOCl can cause the activation
of the transcription factor NF-
B in a lymphocytic cell line.
However, the HOCl was added in the presence of whole medium, and this
effect is likely to be caused by the action of secondary chloramines.
Whether either of these mechanisms involves the oxidation of specific
thiols is unknown.
The difference in susceptibility of the protein thiols to HOCl may be related to a number of factors, including accessibility and reactivity. GAPDH is also sensitive to other oxidants (51), and oxidative regulation of its activity may be important more generally (35). Studies have shown that the GAPDH thiol in the active site is particularly reactive and that it is ionized at neutral pH (17). Our finding that treatment of the cells with DTT raises the basal levels of GAPDH suggests that a proportion of this enzyme is oxidized under control conditions. However, Lind and co-workers (32) have recently demonstrated that S-thiolation of GAPDH does not inactivate the enzyme, suggesting that S-thiolation is unlikely to be the mechanism for the inactivation of GAPDH by HOCl.
Although the products of the HOCl-induced oxidation of thiols were not determined in this study, we found very little GSSG or evidence for protein S-thiolation in HOCl-treated endothelial cells. GSH loss was irreversible and actually increased with time, which is consistent with limited GSSG or mixed-disulfide formation. The products are under investigation and will be described elsewhere (unpublished results). In contrast, reincubation of the cells in HBSS or with DTT was able to restore the enzyme activity, suggesting the formation of disulfides or a sulfenic acid, as is seen with other oxidative systems (33, 45). At higher levels of HOCl exposure, the activity of GAPDH and CK was not reliably restored, suggesting that the thiol group was further oxidized to a higher oxidation state, or that there was irreversible modification of another residue on the protein.
We were interested in whether the decreased activity of the glycolytic enzyme GAPDH transcribed to an effect on cellular energy status. ATP levels fell within 10 min of HOCl treatment and decreased further after a 1-h incubation. Although it is unclear whether the early drop in ATP levels is related to GAPDH, the later loss is unlikely to be caused by the inactivation of GAPDH because at this time point enzyme activity was mostly restored. The direct reaction of ATP with HOCl could cause the initial decrease (38) but not the further drop, and several mechanisms could explain this loss of cellular ATP. A decrease in ATP synthesis either by impairment of glycolysis (other than GAPDH inhibition) or mitochondrial oxidative phosphorylation is one possibility. Alternatively, HOCl could increase the activity of ATPase pumps in the membrane (47). Loss in ATP caused by the activation of poly(ADP-ribose) polymerase by DNA damage (43) is unlikely, because HOCl is not known to cause alterations in DNA at sublethal levels (44).
In summary, our results show that at sublethal levels HOCl causes a loss of cell thiols. The results suggest that this oxidant may be able to regulate cell function by altering the redox balance of the cell or by selectively reacting with thiol proteins that control critical cell processes. The endothelial cell is a particularly relevant model for this interaction because of its unique association with neutrophils in the inflammatory response. Further work is required to characterize these reactions and to determine their significance.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. John Babson for help in setting up the glutathione assay.
| |
FOOTNOTES |
|---|
This work was supported by the Health Research Council of New Zealand and the University of Otago in Dunedin, New Zealand.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: J. Pullar, Free Radical Research Group, Christchurch School of Medicine, PO Box 4345, Christchurch, New Zealand (E-mail: juliet.pullar{at}chmeds.ac.nz).
Received 19 November 1998; accepted in final form 20 May 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Albrich, J. M.,
J. H. Gilbaugh, III,
K. B. Callahan,
and
J. K. Hurst.
Effects of the putative neutrophil-generated toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli.
J. Clin. Invest.
78:
177-184,
1986.
2.
Allison, W. S.
Formation and reactions of sulfenic acids in proteins.
Acc. Chem. Res.
9:
293-299,
1976.
3.
Barchowsky, A.,
S. R. Munro,
S. J. Morana,
M. P. Vincenti,
and
M. Treadwell.
Oxidant-sensitive and phosphorylation-dependent activation of NF-
B and AP-1 in endothelial cells.
Am. J. Physiol.
269 (Lung Cell. Mol. Physiol. 13):
L829-L836,
1995
4.
Barrette, W. C., Jr.,
D. M. Hannum,
W. D. Wheeler,
and
J. C. Hurst.
General mechanism for the bacterial toxicity of hypochlorous acid: abolition of ATP production.
Biochemistry
28:
9172-9178,
1989[Medline].
5.
Beutler, E.
Red Cell Metabolism: A Manual of Biochemical Methods. Orlando, FL: Grune and Stratton, 1984.
6.
Burdon, R. H.
Superoxide and hydrogen peroxide in relation to mammalian cell proliferation.
Free Radic. Biol. Med.
18:
775-794,
1995[Medline].
7.
Carr, A. C.,
and
C. C. Winterbourn.
Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid.
Biochem. J.
327:
275-281,
1997.
8.
Cotgreave, I. A.,
and
P. Moldeus.
Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems.
J. Biochem. Biophys. Methods
13:
231-249,
1986[Medline].
9.
Dallegri, F.,
R. Goretti,
A. Ballestrero,
L. Ottonello,
and
F. Patrone.
Neutrophil induced depletion of adenosine triphosphate in target cells: evidence for a hypochlorous acid-mediated process.
J. Lab. Clin. Med.
112:
765-772,
1988[Medline].
10.
De Bono, D. P.,
and
W. D. Yang.
Exposure to low concentrations of hydrogen peroxide causes delayed endothelial cell death and inhibits proliferation of surviving cells.
Atherosclerosis
114:
235-245,
1995[Medline].
11.
Decker, T.,
and
M. L. Lohmann-Matthes.
A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity.
J. Immunol. Methods
15:
61-69,
1988.
12.
DeLuca, M.,
and
W. McElroy.
Purification and properties of firefly luciferase.
Methods Enzymol.
57:
3-15,
1978.
13.
Duhe, R. J.,
G. A. Evans,
R. A. Erwin,
R. A. Kirken,
G. W. Cox,
and
W. L. Farrar.
Nitric oxide and thiol redox regulation of Janus kinase activity.
Proc. Natl. Acad. Sci. USA
95:
126-131,
1998
14.
Folkes, L. K.,
L. P. Candeias,
and
P. Wardman.
Kinetics and mechanisms of hypochlorous acid reactions.
Arch. Biochem. Biophys.
323:
120-126,
1995[Medline].
15.
Gardner, A. M.,
F. Xu,
C. Fady,
F. J. Jacoby,
D. C. Duffey,
Y. Tu,
and
A. Lichtenstein.
Apoptotic vs. nonapoptotic cytotoxicity-induced by hydrogen peroxide.
Free Radic. Biol. Med.
22:
73-83,
1997[Medline].
16.
Gazda, M.,
and
D. W. Margerum.
Reactions of monochloramine with Br2, Br3
, HOBr, and OBr
: formation of bromochloramines.
Inorganic Chemistry
33:
118-123,
1994.
17.
Gilbert, H. F.
Molecular and cellular aspects of thiol-disulfide exchange.
Advances in Enzymology
63:
69-172,
1990.
18.
Grisham, M. B.,
T. S. Gaginella,
C. von Ritter,
H. Tamai,
R. M. Be,
and
D. N. Granger.
Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability.
Inflammation
14:
531-542,
1990[Medline].
19.
Guyton, K. Z.,
M. Gorospe,
T. W. Kensler,
and
N. J. Holbrook.
Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion.
Cancer Res.
56:
3480-3485,
1996
20.
Halliwell, B.
Free radicals, proteins and DNA: oxidative damage versus redox regulation.
Biochem. Soc. Trans.
24:
1023-1027,
1996[Medline].
21.
Hammerschmidt, S.,
and
H. Wahn.
Comparable effects of HOCl and of FMLP-stimulated PMN on the circulation in an isolated lung model.
Am. J. Respir. Crit. Care Med.
156:
924-931,
1997
22.
Hampton, M. B.,
A. J. Kettle,
and
C. C. Winterbourn.
Inside the neutrophil phagosome: oxidants, myeloperoxidase and bacterial killing.
Blood
92:
3007-3017,
1998
23.
Hazen, S. L.,
and
J. W. Heinecke.
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
J. Clin. Invest.
99:
2075-2081,
1997[Medline].
24.
Hurst, J. K.,
W. C. J. Barrette,
B. R. Michel,
and
H. Rosen.
Hypochlorous acid and myeloperoxidase-catalysed oxidation of iron-sulfur clusters in bacterial respiratory dehydrogenases.
Eur. J. Biochem.
202:
1275-1282,
1991[Medline].
25.
Jacquier-Sarlin, M. R.,
and
B. S. Polla.
Dual regulation of heat-shock transcription factor (HSF) activation and DNA-binding activity by H2O2: role of thioredoxin.
Biochem. J.
318:
187-193,
1996.
26.
Jaffe, E.,
R. L. Nachman,
C. G. Becker,
and
C. R. Minick.
Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria.
J. Clin. Invest.
52:
2745-2756,
1973.
27.
Kettle, A. J.,
and
C. C. Winterbourn.
Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid.
Biochem. J.
252:
529-536,
1988[Medline].
28.
Kettle, A. J.,
and
C. C. Winterbourn.
Assays for the chlorination activity of myeloperoxidase.
Methods Enzymol.
233:
502-512,
1994[Medline].
29.
Klebanoff, S. J.
Myeloperoxidase: occurrence and biological function.
In: Peroxidases in Chemistry and Biology, edited by J. Everse,
K. E. Everse,
and M. B. Grisham. Boca Raton, FL: CRC, 1991, p. 1-35.
30.
Li, J. Z.,
R. Sharma,
K. N. Dileepan,
and
V. J. Savin.
Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid.
Kidney Int.
46:
1025-1030,
1994[Medline].
31.
Lin, K.-T.,
J.-Y. Xue,
M. C. Lin,
E. G. Spokas,
F. F. Sun,
and
P. Y. K. Wong.
Peroxynitrite induces apoptosis of HL-60 cells by activation of a caspase-3 family protease.
Am. J. Physiol.
274 (Cell Physiol. 43):
C855-C860,
1998
32.
Lind, C.,
R. Gerdes,
I. Schuppe-Koistinen,
and
I. Cotgreave.
Studies on the mechanism of oxidative modification of human glyceraldehyde-3-phosphate dehydrogenase by glutathione: catalysis by glutaredoxin.
Biochem. Biophys. Res. Commun.
247:
481-486,
1998[Medline].
33.
Little, C.,
and
P. J. O'Brien.
Mechanism of peroxide-inactivation of the sulphydryl enzyme glyceraldehyde-3-phophate dehydrogenase.
Eur. J. Biochem.
10:
533-538,
1969[Medline].
34.
Malle, E.,
C. Woenckhaus,
G. Waeg,
H. Esterbauer,
E. F. Grone,
and
H.-J. Grone.
Immunological evidence for hypochlorite-modified proteins in human kidney.
Am. J. Pathol.
150:
603-615,
1997[Abstract].
35.
Mallozzi, C.,
A. M. M. Di Stasi,
and
M. Minetti.
Free radicals induce reversible membrane-cytoplasm translocation of glyceraldehyde-3-phospate dehydrogenase in human erythrocytes.
Arch. Biochem. Biophys.
321:
345-352,
1995[Medline].
36.
Martin, J.,
and
I. N. H. White.
Fluorimetric determination of oxidised and reduced glutathione in cells and tissues by high-performance liquid chromatography following derivatisation with dansyl chloride.
J. Chromatogr.
568:
219-225,
1991[Medline].
37.
McKenzie, S. J.,
M. S. Baker,
G. D. Buffinton,
and
W. F. Doe.
Evidence of oxidant induced injury to epithelial cells during inflammatory bowel disease.
J. Clin. Invest.
98:
136-141,
1996[Medline].
38.
Prutz, W. A.
Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates.
Arch. Biochem. Biophys.
332:
110-120,
1996[Medline].
39.
Rao, G. N.
hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases.
Oncogene
13:
713-719,
1996[Medline].
40.
Schiller, J.,
J. Arnhold,
K. Sonntag,
and
K. Arnold.
NMR studies on human, pathologically changed synovial fluids: role of hypochlorous acid.
Magn. Reson. Med.
35:
848-853,
1996[Medline].
41.
Schoonbroodt, S.,
S. Legrand-Poels,
M. Best-Belpomme,
and
J. Piette.
Activation of the NF-
B transcription factor in a T-lymphocytic cell line by hypochlorous acid.
Biochem. J.
321:
777-785,
1997.
42.
Schraufstatter, I. U.,
K. Browne,
A. Harris,
P. A. Hyslop,
J. H. Jackson,
O. Quehenberger,
and
C. G. Cochrane.
Mechanisms of hypochlorite injury to target cells.
J. Clin. Invest.
85:
554-562,
1990.
43.
Schraufstatter, I. U.,
P. A. Hyslop,
D. B. Hinshaw,
R. G. Spragg,
L. A. Sklar,
and
C. G. Cochrane.
Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.
Proc. Natl. Acad. Sci USA
83:
4908-4912,
1986
44.
Schraufstatter, I.,
P. A. Hyslop,
J. H. Jackson,
and
C. G. Cochrane.
Oxidant induced DNA Damage of Target Cells.
J. Clin. Invest.
82:
1040-1050,
1988.
45.
Schuppe, I.,
P. Moldeus,
and
I. A. Cotgreave.
Protein-specific S-thiolation in human endothelial cells during oxidative stress.
Biochem. Pharmacol.
44:
1757-1764,
1992[Medline].
46.
Sen, C. K.
redox signaling and the emerging therapeutic potential of thiol antioxidants.
Biochem. Pharmacol.
55:
1747-1758,
1998[Medline].
47.
Spragg, R. G.,
D. B. Hinshaw,
P. A. Hyslop,
I. U. Schraufstatter,
and
C. G. Cochrane.
Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury.
J. Clin. Invest.
76:
1471-1476,
1985.
48.
Tatsumi, T.,
and
H. Fliss.
Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc.
Am. J. Physiol.
267 (Heart Circ. Physiol. 36):
H1597-H1607,
1994
49.
Thomas, C.,
A. C. Carr,
and
C. C. Winterbourn.
Free radical inactivation of rabbit muscle creatine kinase: Catalysis by physiological iron chelates and hydrolysed ICRF-187 (ICRF-198).
Free Radic. Res.
21:
387-397,
1994[Medline].
50.
Thomas, E. L.,
M. B. Grisham,
and
M. M. Jefferson.
Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils.
J. Clin. Invest.
72:
441-454,
1983.
51.
Vaidyanathan, V. V.,
P. S. Sastry,
and
T. Ramasarma.
Regulation of the activity of glyceraldehyde 3-phosphate dehydrogenase by glutathione and H2O2.
Mol. Cell. Biochem.
129:
57-65,
1993[Medline].
52.
Vermes, I.,
C. Haanen,
H. Steffens-Nakken,
and
C. Reutelingsperger.
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.
J. Immunol. Methods
184:
39-51,
1995[Medline].
53.
Vile, G. F.,
L. A. Rothwell,
and
A. J. Kettle.
Hypochlorous acid activates the tumor suppressor protein p53 in cultured human skin fibroblasts.
Arch. Biochem. Biophys.
359:
51-56,
1998[Medline].
54.
Vissers, M. C. M.,
A. C. Carr,
and
A. L. P. Chapman.
A comparison of human red cell lysis by hypochlorous and hypobromous acid: insights into the mechanism of lysis.
Biochem. J.
330:
131-138,
1998.
55.
Vissers, M. C. M.,
and
J. C. Fantone.
Inhibition of hypochlorous acid-mediated reactions by desferrioxamine. Implications for the mechanism of cellular injury by neutrophils.
Free Radic. Biol. Med.
8:
331-337,
1990[Medline].
56.
Vissers, M. C. M.,
A. Stern,
F. Kuypers,
J. J. M. van den Berg,
and
C. C. Winterbourn.
Membrane changes associated with lysis of red blood cells by hypochlorous acid.
Free Radic. Biol. Med.
16:
703-712,
1994[Medline].
57.
Vissers, M. C. M.,
and
C. C. Winterbourn.
Oxidative damage to fibronectin. I. The effects of the neutrophil myeloperoxidase system and HOCl.
Arch. Biochem. Biophys.
285:
53-59,
1991[Medline].
58.
Vissers, M. C. M.,
and
C. C. Winterbourn.
Oxidation of intracellular glutathione after exposure of red cells to hypochlorous acid.
Biochem. J.
307:
57-62,
1995.
59.
Werns, S. W.,
and
B. R. Lucchesi.
Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion.
Free Radical Biol. Med.
4:
31-37,
1988[Medline].
60.
Whisler, R. L.,
M. A. Goyette,
I. S. Grants,
and
Y. G. Newhouse.
Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells.
Arch. Biochem. Biophys.
319:
23-35,
1998.
61.
Winterbourn, C. C.
Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite.
Biochim. Biophys. Acta
840:
204-210,
1985[Medline].
62.
Winterbourn, C. C.,
J. J. M. van den Berg,
E. Roitman,
and
F. A. Kuypers.
Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid.
Arch. Biochem. Biophys.
296:
547-555,
1992[Medline].
This article has been cited by other articles:
![]() |
M. C. M. Vissers, W.-G. Lee, and M. B. Hampton Regulation of Apoptosis by Vitamin C. SPECIFIC PROTECTION OF THE APOPTOTIC MACHINERY AGAINST EXPOSURE TO CHLORINATED OXIDANTS J. Biol. Chem., December 7, 2001; 276(50): 46835 - 46840. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pullar, M. C. M. Vissers, and C. C. Winterbourn Glutathione Oxidation by Hypochlorous Acid in Endothelial Cells Produces Glutathione Sulfonamide as a Major Product but Not Glutathione Disulfide J. Biol. Chem., June 15, 2001; 276(25): 22120 - 22125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Jenner, J. E. Ruiz, C. Dunster, B. Halliwell, G. E. Mann, and R. C.M. Siow Vitamin C Protects Against Hypochlorous Acid-Induced Glutathione Depletion and DNA Base and Protein Damage in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 5, 2002; 22(4): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |